numero speciale Seminars in Cancer Biology
This call for thematic issue will be open starting from March 2020:
Relationships between the Cancer, Cardiovascular and Alzheimer diseases via the oxidative stress induced mitochondrial overproliferation and deletion as a target for the treatment. Recent Challenges
This is can be as basic or clinical review paper. Please adapt review under this topic if it is possible to make sure that general point of view going to fit this journal :This topic also going to cover implication of natural products in the context of Cancer, Atherosclerosis as well as Alzheimer's disease or other disorders.
Relationships between the Cancer, Cardiovascular and Alzheimer diseases via the oxidative stress induced mitochondrial overproliferation and deletion as a target for the treatment. Recent Challenges
This is can be as basic or clinical review paper. Please adapt review under this topic if it is possible to make sure that general point of view going to fit this journal :This topic also going to cover implication of natural products in the context of Cancer, Atherosclerosis as well as Alzheimer's disease or other disorders.
Manuscript submission March 31, 2020.
Review, Revision and final decision: May 31, 2020.
Publication: June 2020
Guest editor
Gjumrakch Aliev, MD&PhD
President "GALLY" International Biomedical Research Consulting LLC
San Antonio, TX, USA;
pubmed references:
Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion.
Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA.
Oxid Med Cell Longev. 2013;2013:962984. doi: 10.1155/2013/962984.
Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA Jr, Benberin VV, Bachurin SO.
Curr Med Chem. 2014;21(19):2208-17. Review.
Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, Gąsiorowski K, Leszek J, Aliev G.
CNS Neurol Disord Drug Targets. 2011 Mar;10(2):175-83.
Commenti
Posta un commento